Related Experiment Video
Updated: Apr 21, 2026
05:55
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
1.4K
Multiple myeloma presenting with autoimmune hemolytic anemia
Binay Kumar Shah1, Dipesh Uprety1, David Tretheway1
1St. Joseph Regional Cancer Center, 1250 Idaho Street, Lewiston, ID 83501 USA.
Summary
Autoimmune hemolytic anemia is a rare initial symptom of multiple myeloma. This case highlights the importance of considering this rare presentation in diagnosing multiple myeloma.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Multiple myeloma is a malignant plasma cell disorder.
- Autoimmune hemolytic anemia (AIHA) is characterized by antibody-mediated red blood cell destruction.
- AIHA is an uncommon complication in multiple myeloma.
Observation:
- A rare case of multiple myeloma presenting with AIHA is described.
- The patient exhibited symptoms of autoimmune hemolysis at the time of initial diagnosis.
Findings:
- This case underscores the infrequent association between multiple myeloma and AIHA at initial presentation.
- The concurrent occurrence of these conditions poses diagnostic challenges.
Implications:
- Early recognition of AIHA in multiple myeloma is crucial for timely diagnosis and treatment.
- This case expands the understanding of the clinical spectrum of multiple myeloma.
- Further research may elucidate the underlying mechanisms linking multiple myeloma and AIHA.
More Related Videos
10:55Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
1.1K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.1K
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
5
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
5
01:31Hybridoma Technology
13.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.0K
01:29Autoimmune Disorders
2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
01:01Hypersensitivity Reactions: Cytolytic Reactions
196
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
196
01:27Disorders of Leukocytes
2.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.2K
01:22Myasthenia Gravis ll: Pathophysiology
18
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
18